Evaluation of the effectiveness of lipid-lowering therapy (bile acid sequestrants, niacin, psyllium and lovastatin) for treating hypercholesterolemia in veterans.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  American Journal of Cardiology

• Publication date

  1993-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9149(93)90820-3PMID 8456750
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatic toxicity of unmodified and time-release preparations of niacin.

  1992cited by this paper
• Drug Therapy in the Elderly

  1992cited by this paper
• Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia.

  1991cited by this paper
• Niacin revisited: clinical observations on an important but underutilized drug.

  1991cited by this paper
• Dyslipidemia in veterans. Multiple risk factors may break the bank.

  1991cited by this paper
• Hypocholesterolemic effects of different bulk-forming hydrophilic fibers as adjuncts to dietary therapy in mild to moderate hypercholesterolemia.

  1991cited by this paper
• Effects of Simvastatin and Cholestyramine in Familial and Nonfamilial Hypercholesterolemia

  1990cited by this paper
• Comparison of psyllium hydrophilic mucilloid and cellulose as adjuncts to a prudent diet in the treatment of mild to moderate hypercholesterolemia.

  1990cited by this paper
• The role of Veterans Affairs hospitals in the health care system.

  1990cited by this paper
• The role of Veterans Affairs hospitals in the health care system.

  1990cited by this paper
• Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.

  1990cited by this paper
• Cholesterol-lowering effects of psyllium hydrophilic mucilloid. Adjunct therapy to a prudent diet for patients with mild to moderate hypercholesterolemia.

  1989cited by this paper
• Effect of a modified, well-tolerated niacin regimen on serum total cholesterol, high density lipoprotein cholesterol and the cholesterol to high density lipoprotein ratio.

  1989cited by this paper
• Adherence and Medication Instructions Review and Recommendations

  1988cited by this paper
• Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hypercholesterolemic men.

  1988cited by this paper
• A General Method of Compliance Assessment Using Centralized Pharmacy Records: Description and Validation

  1988cited by this paper
• Effect of low-dose niacin on high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol ratio.

  1988cited by this paper
• Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study.

  1987cited by this paper
• Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin.

  1985cited by this paper
• The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.

  1984cited by this paper
• Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia.

  1982cited by this paper
• Clofibrate and niacin in coronary heart disease.

  1975cited by this paper
• Medication use and misuse: physician-patient discrepancies.

  1975cited by this paper
• Compliance as a determinant of serum digoxin concentration.

  1973cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper
• Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions.

  1970cited by this paper

• Psyllium supplementation and lipid profiles: systematic review and dose-response meta-analysis of randomized controlled trials

  2025cites this paper
• Chapter 8 – Psyllium Polysaccharide

  2018cites this paper
• Extraction process and cholesterol-lowering property of dietary fiber from cassava pulp

  2016cites this paper
• Pathways and costs of care for patients with tuberculosis symptoms in rural Uganda.

  2015cites this paper
• Patient Adherence with HMG Reductase Inhibitor Therapy among Users of Two Types of Prescription

  2015cites this paper
• Evaluating the role of primary care physicians in the treatment of latent tuberculosis: a population study.

  2014cites this paper
• Exploring The Role Of Psyllium Husk As Therapeutic Agent In Human Subjects

  2012cites this paper
• A "hot" topic in dyslipidemia management--"how to beat a flush": optimizing niacin tolerability to promote long-term treatment adherence and coronary disease prevention.

  2010cites this paper
• Dietary omega-3 fatty acids, nutritional preconditioning of the heart against ischemic injury

  2010cites this paper
• Cardiovascular Medications: Pharmacokinetics and Pharmacodynamics

  2009cites this paper
• Microsoft Word-06

  2009cites this paper
• Lipid-lowering drugs acting at the level of the gastrointestinal tract.

  2009cites this paper
• Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemia

  2008cites this paper
• Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemia.

  2008cites this paper
• Cholesterol reduction using psyllium husks - do gastrointestinal adverse effects limit compliance? Results of a specific observational study.

  2008cites this paper
• Cholesterol in patients with coronary heart disease

  2007cites this paper
• THE EFFECT OF LOW-DOSE NIACIN ADDED TO SIMVASTATIN ON LIPOPROTEIN PROFILE

  2007cites this paper
• Clinical evidence for use of acetyl salicylic acid in control of flushing related to nicotinic acid treatment

  2006cites this paper
• Effect of time of administration on cholesterol-lowering by psyllium: a randomized cross-over study in normocholesterolemic or slightly hypercholesterolemic subjects

  2004cites this paper
• Optimal management of hyperlipidemia in primary prevention of cardiovascular disease.

  2004cites this paper
• Vitamin Therapy for Cardiovascular Disease

  2004cites this paper
• Using pharmacy claims data to evaluate adherence and persistence with prescribed medications in patients with diabetes mellitus

  2004cites this paper
• Absorption of Colesevelam Hydrochloride in Healthy Volunteers

  2002cites this paper
• Effect of very-low-dose niacin on high-density lipoprotein in patients undergoing long-term statin therapy.

  2002cites this paper
• Patient Adherence and Medical Treatment Outcomes

  2002cites this paper
• Patient Adherence and Medical Treatment Outcomes: A Meta-Analysis

  2002cites this paper
• Patient Adherence with HMG Reductase Inhibitor Therapy among Users of Two Types of Prescription Services

  2002cites this paper
• Poor Adherence with Hypolipidemic Drugs: A Lost Opportunity

  2001cites this paper
• Colesevelam Hydrochloride: A Novel Bile Acid-Binding Resin

  2001cites this paper
• Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trial.

  2001cites this paper
• Indigenous drugs and atherosclerosis.

  2001cites this paper
• Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence.

  2000cites this paper
• Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects.

  1999cites this paper
• Combination drug therapy for dyslipidemia

  1999cites this paper
• Discontinuation rates of cholesterol-lowering medications: implications for primary care.

  1999cites this paper
• REDUCTION IN SERUM TOTAL AND LDL CHOLESTEROL CONCENTRATIONS BY A DIETARY FIBER AND POLYPHENOL-RICH GRAPE PRODUCT IN HYPERCHOLESTEROLEMIC RATS

  1999cites this paper
• Compliance in the real world.

  1998cites this paper
• What is happening in the real world in lipid therapy and is it appropriate? The need for a paradigm shift.

  1998cites this paper
• Experience with Crystalline Niacin as the Preferred Drug for Dyslipidemia in a Specialty Clinic

  1997cites this paper
• Effect of Pharmaceutical Care on Optimum Colestipol Treatment in Elderly Hypercholesterolemic Veterans

  1997cites this paper
• Interaction between Potassium-Depleting Diuretics and Lovastatin in Hypercholesterolemic Ambulatory Care Patients

  1997cites this paper
• Effective lovastatin therapy in elderly hypercholesterolemic patients - an antioxidative impact?

  1996cites this paper
• Management of hyperlipidaemia

  1996cites this paper
• Cholesterol-reduction intervention study (CRIS): a randomized trial to assess effectiveness and costs in clinical practice.

  1996cites this paper
• Physician extenders for cost-effective management of hypercholesterolemia

  1996cites this paper
• Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals.

  1996cites this paper
• Dose-Response Characteristics of Cholesterol-Lowering Drug Therapies: Implications for Treatment

  1996cites this paper
• Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

  1995cites this paper
• Psyllium in Hypercholesterolemia

  1995cites this paper
• Cholesterol in patients with coronary heart disease

  1995cites this paper
• Risk factor intervention and coronary artery disease: clinical strategies.

  1995cites this paper
• Therapy with HMG CoA reductase inhibitors: characteristics of the long-term permanence of hypocholesterolemic activity.

  1995cites this paper
• Lipid-lowering efficacy of psyllium hydrophilic mucilloid in non insulin dependent diabetes mellitus with hyperlipidaemia.

  1994cites this paper
• Efficacy of dietary fiber in lowering serum cholesterol.

  1994cites this paper
• Niacin: a therapeutic dilemma. "One man's drink is another's poison".

  1994cites this paper
• Fluvastatin with and without niacin for hypercholesterolemia.

  1994cites this paper
• Telephone Contacts Do Not Improve Adherence to Niacin or Bile Acid Sequestrant Therapy

  1994cites this paper
• Management of Older Adults with Hypercholesterolaemia

  1994cites this paper
• Patient-directed, nonprescription approaches to cardiovascular disease.

  1994cites this paper
• Nurse practitioners as endoscopists.

  1994cites this paper
• Nurse practitioners as endoscopists.

  1994cites this paper
• Variabilityof LipidMeasurements: Relevanceforthe Clinician

  1993cites this paper
• Combination drug therapy for hypercholesterolemia. The trade-off between cost and simplicity.

  1993cites this paper
• Variability of lipid measurements: relevance for the clinician.

  1993cites this paper